Rebecca L. Clegg
{ Bio Portrait }

Rebecca Clegg's practice focuses on complex intellectual property litigation and counseling, particularly in the fields of medical devices, pharmaceuticals, biotechnology, and semiconductors. Rebecca regularly litigates medical device and Hatch-Waxman Paragraph IV patent infringement suits. She also has experience representing clients in commercial litigation cases.

Rebecca received her law degree from the University of Connecticut School of Law, which she attended on a full-tuition merit scholarship. While at UConn Law, she served as Competition Editor for the Connecticut Law Review, worked in the Intellectual Property and Entrepreneurship Law Clinic, and earned multiple CALI Excellence for the Future Awards. Rebecca was a summer associate with Axinn in 2014. She graduated magna cum laude from Mount Holyoke College in 2012 with a degree in History and Physics.

Professional Activities

  • American Bar Association, Intellectual Property Law Section, Science & Technology Law Section, and Young Lawyers Division
  • Connecticut Bar Association, Intellectual Property Section, Co-Chair
  • Connecticut Bar Association, Intellectual Property Section, Legislative Liaison (2020-2024)
  • Connecticut Bar Association, Young Lawyers Section


  • Defended generic pharmaceutical company in a Hatch-Waxman case challenging over 460 claims from 26 patents covering Salix’s blockbuster drug Xifaxan®. Obtained judgment after a four-day bench trial that the patents directed to a method of treatment (IBS-D) and composition of matter (polymorph) were invalid as obvious.
  • Defended generic pharmaceutical company in Hatch-Waxman patent litigation concerning roughly three dozen patents from seven patent families directed to controlled release or abuse deterrent dosage forms.
  • Represented medical device company in patent litigation concerning veterinary surgical plates.
  • Represented multinational corporation in patent litigation relating to its quantum dot television displays.
  • Advised client on patent issues relating to semiconductor fabrication and manufacturing tools.
  • Defended generic pharmaceutical company in Hatch-Waxman case concerning 18 patents and over 400 patent claims regarding lisdexamphetamine capsules.
  • Represented developer of wireless communications modules in ITC investigation and obtained final determination of no violation on multiple grounds.
  • Defended generic pharmaceutical company in Hatch-Waxman patent litigation involving a boronic acid proteasome inhibitor.
  • Defended financial industry service provider from multiple indemnification claims brought by bank.
  • Represented pro bono client in a civil rights suit and obtained a settlement with an economic value of more than $1 million.



  • JD – University of Connecticut School of Law (2015)
  • BA, magna cum laude – Mount Holyoke College (2012)


  • Connecticut
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court District of Connecticut

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.